Skip to main content
Log in

Chronic pelvic pain syndrome and voiding dysfunction

  • Published:
Current Prostate Reports

Abstract

Chronic prostatitis/chronic pelvic pain syndrome is a disease that is mainly characterized by three parameters: pain in the suprapubic and pelvic area, presence or absence of white blood cells in expressed prostatic secretions, and voiding disorders of various degrees. The causative factors underlying this very common condition are poorly understood. Therapeutic options (ie, antimicrobial treatment) often are based on the presence of an inflammatory reaction in the expressed prostatic secretions, but the benefit of recurring or prolonged courses of antimicrobial agents is highly variable. Observations have been made regarding functional and structural changes in the lower urinary tract that are suggestive to have an impact on the pathogenesis of chronic pelvic pain syndrome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References and Recommended Reading

  1. Collins MM, Stafford RS, O’Leary MP, et al.: How common is prostatitis? A national survey of physician visits. J Urol 1998, 159:1224–1228.

    Article  PubMed  CAS  Google Scholar 

  2. de la Rosette JJ, Hubregtse MR, Meuleman EJ, et al.: Diagnosis and treatment of 409 patients with prostatitis syndromes. Urology 1993, 41:301–307.

    Article  PubMed  Google Scholar 

  3. Krieger JN, Nyberg L Jr, Nickel JC: NIH consensus definition and classification of prostatitis. JAMA 1999, 282:236–237.

    Article  PubMed  CAS  Google Scholar 

  4. Nickel JC, Costerton JW: Coagulase-negative staphylococcus in chronic prostatitis. J Urol 1992, 147:391–400.

    Google Scholar 

  5. Tanner MA, Shoskes D, Shahed A, et al.: Prevalence of corynebacterial 16S rRNA sequences in patients with bacterial and "nonbacterial" prostatitis. J Clin Microbiol 1999, 37:1863–1870.

    PubMed  CAS  Google Scholar 

  6. Krieger JN, Riley DE, Vesella RL, et al.: Bacterial DNA sequences in prostate tissue from patients with prostate cancer and chronic prostatitis. J Urol 2000, 164:1221–1228.

    Article  PubMed  CAS  Google Scholar 

  7. Weidner W, Diemer T, Huwe P, et al.: The role of Chlamydia trachomatis in prostatitis. Int J Antimicrob Agents 2002, 19:466–470.

    Article  PubMed  CAS  Google Scholar 

  8. Nickel JC: Prostatitis: lessons from the 20th century. BJU Int 2000, 85:179–185.

    Article  PubMed  CAS  Google Scholar 

  9. Schaeffer AJ, Knauss JS, Landis JR, et al.: Leukocyte and bacterial counts do not correlate with severity of symptoms in men with chronic prostatitis: the National Institutes of Health Chronic Prostatitis Cohort Study. J Urol 2002, 168:1048–1053. This study emphasizes the importance of considering the role of other organs and systems rather than the prostate alone in the etiology of CPPS.

    Article  PubMed  Google Scholar 

  10. Kirby RS, Lowe D, Bultitude MI, et al.: Intra-prostatic urinary reflux: an aetiological factor in abacterial prostatitis. Br J Urol 1982, 54:729–731.

    Article  PubMed  CAS  Google Scholar 

  11. Kaplan SA, Ikeguchi EF, Santarosa RP, et al.: Etiology of voiding dysfunction in men less than 50 years of age. Urology 1996, 47:836–839. This study recommends urodynamic evaluation in the presence of chronic voiding dysfunction to establish the correct diagnosis and avoid unnecessary antibiotic treatment.

    Article  PubMed  CAS  Google Scholar 

  12. Barbalias GA: Prostatodynia or painful male urethral syndrome? Urology 1990, 36:146–153.

    Article  PubMed  CAS  Google Scholar 

  13. Mehik A, Hellstrom P, Nickel JC, et al.: The chronic prostatitis-chronic pelvic pain syndrome can be characterized by prostatic tissue pressure measurements. J Urol 2002, 167:137–140. This paper suggests that inflammatory CPPS may be a form of compartmental syndrome.

    Article  PubMed  Google Scholar 

  14. Blacklock NJ: The anatomy of the prostate: relationship with prostatic infection. Infection 1991, 19(suppl 3):S111-S114.

    Article  PubMed  Google Scholar 

  15. Hruz P, Danuser H, Studer UE, et al.: Non-inflammatory chronic pelvic pain syndrome can be caused by bladder neck hypertrophy. Eur Urol 2003, 44:106–110. This report provides evidence of bladder outlet obstruction in men with CPPS correlating endoscopic and objective urodynamic parameters.

    Article  PubMed  Google Scholar 

  16. Kunisawa Y, Kawabe K, Niijima T, et al.: A pharmacological study of alpha adrenergic receptor subtypes in smooth muscle of human urinary bladder base and prostatic urethra. J Urol 1985, 134:396–398.

    PubMed  CAS  Google Scholar 

  17. Restorick JM, Mundy AR: The density of cholinergic and alpha and beta adrenergic receptors in the normal and hyperreflexic human detrusor. Br J Urol 1989, 63:32–35.

    Article  PubMed  CAS  Google Scholar 

  18. Krane RJ, Olsson CA: Phenoxybenzamine in neurogenic bladder dysfunction. I: a theory of micturition. J Urol 1973, 110:650–652.

    PubMed  CAS  Google Scholar 

  19. Nickel JC, Nyberg LM, Hennenfent M: Research guidelines for chronic prostatitis: consensus report from the first National Institutes of Health International Prostatitis Collaborative Network. Urology 1999, 54:229–233.

    Article  PubMed  CAS  Google Scholar 

  20. Cheah PY, Liong ML, Yuen KH, et al.: Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized, placebo controlled trial. J Urol 2003, 169:592–596.

    Article  PubMed  CAS  Google Scholar 

  21. Ishizuka O, Persson K, Mattiasson A, et al.: Micturition in conscious rats with and without bladder outlet obstruction: role of spinal alpha 1-adrenoceptors. Br J Pharmacol 1996, 117:962–966.

    Article  PubMed  CAS  Google Scholar 

  22. Barbalias GA, Nikiforidis G, Liatsikos EN: Alpha-blockers for the treatment of chronic prostatitis in combination with antibiotics. J Urol 1998, 159:883–887.

    Article  PubMed  CAS  Google Scholar 

  23. Mehik A, Alas P, Nickel JC, et al.: Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study. Urology 2003, 62:425–429.

    Article  PubMed  Google Scholar 

  24. Mense S: Nociception from skeletal muscle in relation to clinical muscle pain. Pain 1993, 54:241–289.

    Article  PubMed  CAS  Google Scholar 

  25. Zermann DH, Ishigooka M, Doggweiler R, et al.: Neurourological insights into the etiology of genitourinary pain in men. J Urol 1999, 161:903–908.

    Article  PubMed  CAS  Google Scholar 

  26. Clemens JQ, Nadler RB, Schaeffer AJ, et al.: Biofeedback, pelvic floor re-education, and bladder training for male chronic pelvic pain syndrome. Urology 2000, 56:951–955. Interesting treatment option for patients with CPPS.

    Article  PubMed  CAS  Google Scholar 

  27. Anderson RU: Management of chronic prostatitis-chronic pelvic pain syndrome. Urol Clin North Am 2002, 29:235–239.

    Article  PubMed  Google Scholar 

  28. Shoskes DA, Hakim L, Ghoniem G, et al.: Long-term results of multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome. J Urol 2003, 169:1406–1410. This study focuses on the heterogeneous nature of CPPS. The recommended stepwise and multimodal treatment approach is pragmatic and seems to be quite efficient.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hochreiter, W.W., Z’Brun, S. Chronic pelvic pain syndrome and voiding dysfunction. Curr prostate rep 2, 42–46 (2004). https://doi.org/10.1007/s11918-004-0042-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11918-004-0042-5

Keywords

Navigation